GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » Research & Development

Agilon Health (Agilon Health) Research & Development : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Agilon Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Agilon Health's Research & Development for the three months ended in Dec. 2023 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.


Agilon Health Research & Development Historical Data

The historical data trend for Agilon Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health Research & Development Chart

Agilon Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- - - - -

Agilon Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Agilon Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilon Health  (NYSE:AGL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Agilon Health Research & Development Related Terms

Thank you for viewing the detailed overview of Agilon Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilon Health (Agilon Health) Business Description

Traded in Other Exchanges
N/A
Address
6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
Executives
Jeffrey A. Schwaneke director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell director, officer: CEO & President C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker officer: Chief Markets Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia director 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd. 10 percent owner MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai officer: Chief Strategy & Dev. Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer officer: Chief Med. & Quality Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie director METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak officer: Chief Accounting Officer 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias officer: Chief Business Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley officer: Chief Administrative Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723